Suppression of natural killer (NK) cell activity of spleen cells by thymocytes by Nair, Madhavan P. N. et al.
CELLULAR IMMUNOLOGY 58, 9-18 (1981) 
Suppression of Natural Killer (NK) Cell Activity 
of Spleen Cells by Thymocytes’ 
MADHAVAN P. N. NAIR,’ STANLEY A. SCHWARTZ,* GABRIEL FERNANDES, 
RAJENDRA PAHWA, SUSUMU IKEHARA, AND ROBERT A. GOOD 
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, and 
*Department of Pediatrics, The University of Michigan, Ann Arbor, Michigan 48109 
Received December 31. 1979; accepted May 28. 1980 
The in vitro influence of thymus cells on natural killer cell activity of spleen cells against 
prelabeled target cells (YAC-I and RLbI) has been studied in syngeneicas well as in allogeneic 
murine models. In mixing experiments to demonstrate suppression, total thymocytes have been 
found to have no effect on NK activity of syngeneic or allogeneic spleen cells. Among several 
thymocyte fractions separated by velocity sedimentation, a relatively faster sedimenting frac- 
tion showed remarkable suppression of NK activity by spleen cells against two target cells. 
The suppressive effect of this particular fraction on NK activity was demonstrated to be 
proportional to the cell dose. The suppressive function was resistant to irradiation at 1000 or 
2000 rad administered in vitro and was not restricted by the major histocompatibility complex. 
Moreover, the thymocyte fraction which induced suppression was not sensitive to NK-mediated 
cytolysis by syngeneic spleen cells. The suppression of NK cytolysis in vitro by certain sub- 
populations of thymocytes as observed in the present studies may be consistent with a role for 
the thymus in regulating NK activity in vivo. 
INTRODUCTION 
The regulatory role of thymus-derived (T) cells has recieved considerable atten- 
tion because of their potential acitvity in either amplifying or suppressing antibody 
synthesis, graft rejection, and generation of cytotoxic cells to alloantigens (l-4). 
In studies with thymocytes, Moiser and Johnson (5) had shown suppression of 
plaque-forming activity of adult spleen cells by neonatal thymocytes. Moticka (6) 
demonstrated both a suppressive influence of thymocytes on normal lymphocyte 
proliferative responses to PHA and that thymocytes inhibit the GVH response in 
transfer experiments using a chicken model. 
Recently natural killer (NK)3 cells have been gaining much attention because 
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of a possible role in defense against tumor cells as well as in maintaining regulation 
of lymphoid cell reactions. Nunn et al. (7) and Hansson et al. (8) recently reported 
that a wide range of malignant and nontransformed cells including thymocytes 
from different strains of mice were sensitive to low levels of NK-mediated cytolysis, 
thereby implying that NK cells may be involved in potential homeostatic control 
mechanisms. If NK activity is important in self-regulation of lymphoid cell func- 
tions it seems likely that differentiation, maturation, and function of NK cells 
would also be subject to regulation. The finding of high NK activity in nude and 
neonatally thymectomized mice (9) suggests that thymocytes or cells under thymic 
influence might exert a regulatory influence on NK cells. 
In the present study, we have examined the effect of different thymus cell sub- 
populations fractionated by velocity sedimentation on the NK activity of spleen 
cells against prelabeled YAC-I and RL61 target cells in vitro. We report suppression 
of NK activity of effector spleen cells against both target cells by a pooled fraction 
of syngeneic thymocytes, separated by velocity sedimentation. Cells larger or 
smaller than the active subpopulation did not suppress NK activity of spleen cells 
against either target cells. The suppressive function on the effector cells of the 
active fraction was dose dependent and not restricted by the major histocompati- 
bility complex. The thymocyte fraction which showed suppression was not itself 
susceptible to NK-mediated lysis by syngeneic spleen cells. The results suggest that 
suppression of NK cytolysis by thymus cells in vitro is a manifestation of a thymic- 
dependent regulatory mechanism modulating the level of NK activity in vivo. 
MATERIALS AND METHODS 
Mice. C57B1/6J(B6) and C3H/HeJ (C3H) mice purchased from Jackson Lab- 
oratory, Bar Harbor, Maine, were employed as a source of spleen and thymus cells. 
All mice were used at 5 to 8 weeks of age. 
Preparation of effector cells. Spleen cells were collected in RPM1 1640 medium 
(Grand Island Biological Co., Grand Island, N.Y.) supplemented with 10% fetal 
calf serum (FCS). The cells were released by gently teasing the spleens or thymuses 
in cold medium. Erythrocytes were lysed by treatment with isotonic ammonium 
chloride (0.83%) in 0.016 M Tris buffer (pH 7.2) for 2 min at 4°C and the cells 
were then washed three times in complete medium. Finally the cells were resus- 
pended in complete medium to a concentration of 2 X lo* cells/ml. The cells were 
then passed through a nylon wool column to remove the adherent cells as described 
by Handwerger and Schwartz (10). Monocytes/macrophages were removed by the 
carbonyl iron method as described elsewhere (11). 
Preparation of thymus cells. Thymuses were removed aseptically, minced, and 
gently passed through a fine mesh stainless steel sieve into phosphate-buffered 
saline (PBS). Cell aggregates were disrupted further by repeated aspiration with 
a Pasteur pipet. After removing large cell clumps and debris, the cells were passed 
through the mesh and washed three times with PBS at 4°C. Cell viability was 90 
to 95% as determined by trypan blue dye exclusion. The cells were then separated 
by velocity sedimentation at unit gravity at 4°C according to a modification of the 
method of Miller (12). Details of the separation procedure have been described 
elsewhere (13). Cells were allowed to sediment at 4°C for 4 hr and then collected 
in 35-ml fractions after discarding an initial 250 ml. Thirty fractions were collected. 
The cell concentration in each fraction was determined in a hemocytometer; ad- 
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jacent fractions were pooled when necessary and then washed twice with PBS. 
Total cell recovery was 70 to 85% and cell viability was 90 to 95% as measured 
by trypan blue dye exclusion. 
Assay for NK cell activity. The NK activity was determined in a direct 5’Cr 
release assay as previously described (14). Briefly a fixed number of viable spleen 
cells in complete medium was prepared in varying dilutions to give 50:1, 25: 1, and 
12.5:l effector to target (E:T) cell ratios. The spleen cells were added in triplicate 
to “Cr-labeled target cells in a final volume of 0.2 ml in V-bottom microtiter plates 
(Falcon No. 3041, Rockville, Md.) and following 40g centrifugation for 2 min 
incubated at 37°C in 5% CO1 in air atmosphere for 4 hr. In mixing assays, to 
measure suppressor activity, total thymocytes or fractionated subpopulations of 
thymocytes were added separately to a mixture of effector and target cells. In 
mixing experiments, the E:T cell ratio was maintained at 5O:l whereas the sup- 
pressor to effector (S:E) cell ratio ranged from 1: 1, 2:1, and 3: 1. All plates were 
treated exactly as described for the cytotoxicity assay. Percentage cytotoxicity was 
calculated as follows: 
Percentage lysis = 
experimental release - spontaneous release 
maximal release (Triton x- 100) - spontaneous release 
x 100. 
Tumor cells. RLGI, a cell line derived from radiation-induced T-cell leukemia 
in BALB/c mice (15) and YAC-I, a T-cell lymphoma induced by Moloney virus 
in A/Sri mice obtained through the courtesy of 0. Stutman, Sloan-Kettering In- 
stitute, New York, were used as target cells. All the tumor target cells were main- 
tained in our laboratory by serial passage in vitro in RPM1 1640 medium (Gibco) 
supplemented with 10% FCS, glutamine, and antibiotics. Target cells were labeled 
with 5’Cr as sodium chromate (Radiochemical Center, Amersham, England) as 
described elsewhere ( 14). 
Irradiation of cells. Total thymocytes or their subfractions were irradiated with 
1000 or 2000 rad of y irradiation from a cesium-137 source at a rate of 125 rad/ 
min. The irradiated cells were >98% viable as judged by trypan blue dye exclusion. 
RESULTS 
Suppression of NK Activity of Spleen Cells by Syngeneic Thymus Fractions 
In view of the fact, that nude mice or thymectomized mice showed high levels 
of NK activity (9), the in vitro influence of thymus cells on NK activity of syngeneic 
spleen cells was studied against prelabeled YAC-I and RLBI target cells (Fig. 1). 
In general, cytolysis, as measured by release of “Cr, was higher against YAC-I 
target cells than against RL$I cells. Total thymocytes or thymocytes fractionated 
by velocity sedimentation by themselves did not show cytolytic activity against 
either YAC-I or RLGI target cells (data not presented). Spleen cells, from 5- to 
8-week-old B6 mice, depleted of nylon wool-adherent cells and monocytes/mac- 
rophages showed 20 and 11% cytotoxicity against YAC-I and RLGI target, re- 
spectively. To detect the effect of unfractionated thymocytes or thymocyte fractions 
on effector cell function in NK activity, total thymocytes or their fractions were 
added to functional NK cells from young B6 mice and radiolabeled target cells. 
The results demonstrate that the mixture containing total thymocytes does not 
show a suppressive effect on NK activity of syngeneic spleen cells against YAC- 
I (18% cytotoxicity) or against RLGI (10% cytotoxicity) target cells. Pooled thy- 
mocytes from fractions 15-l 8 showed remarkable suppression of NK activity of 












FIG. 1. Suppression of natural killer cell activity of young B6 spleen cells by autologous thymocytes 
fractionated by velocity sedimentation. Effector cells were depleted of nylon wool-adherent cells and 
monocyte/macrophages. Effector to target cell ratios (E:T) of 50:1, 25:1, and 12.5:1 were used in the 
experiments and dose response cytotoxicity was obtained, but only results of the 5O:l E:T ratio are shown. 
(O)Percentage cytotoxicity against YAC-I. (@Percentage cytotoxicity against RLGI cells. In the sup- 
pressor assay, 5 X 10’ thymocytes or their fractions were added separately to a mixture of 5 X 10’ 
effector cells and 1 X lo4 prelabeled target cells and following 4 hr incubation, percentage cytotoxicity 
was measured as shown under Materials and Methods. A constant suppressor:effector (S:E) cell ratio 
of 1:l has been used. Results are expressed as mean percentage f SE of direct cytotoxicity to target 
cells in triplicate culture of one representative experiment. Five separate experiments gave similar results. 
(a) Percentage cytotoxicity by spleen cells alone; (b) percentage cytotoxicity by spleen cells in presence 
of total thymocytes; (c) percentage cytotoxicity by spleen cells in presence of different thymocyte frac- 
tions. Pooled thymocyte fraction 15-l 8 was the only fraction that showed significant suppression of NK 
activity of autologous spleen cells against both YAC-I and RLBI targets, P x0.01. 
syngeneic spleen cells against YAC-I (9.0% cytotoxicity) or RLBI (4.5% cytotox- 
icity) targets compared to lack of suppression observed with total thymocytes or 
earlier thymocyte fractions 1-14 or later fractions 19, 20, 21, 22, or 23-30. The 
cytotoxicity exerted by spleen cells in cultures containing thymocytes of fractions 
1-14 were 16.0 and 8.0%, respectively, against YAC-I and RLBI target cells. Also 
no suppression of cytotoxicity of spleen cells was obtained by any of the later 
fractions against either YAC-I or RLBI target cells, The results indicate a signif- 
icant suppressive effect (P = ~0.01) on NK activity of spleen cells by syngeneic 
thymocytes from fractions 15-l 8 separated by velocity sedimentation. 
Suppression of NK Activity is Mediated across the Major Histocompatibility 
Barrier 
To test whether the suppressive action can be mediated when thymocytes and 
spleen cells differ at the major histocompatibility complex, thymocytes and thy- 
mocyte fractions from B6 (H2b) mice were mixed with functional splenic NK cells 
from C3H (H-2k) mice and prelabeled YAC-I and RLBI target cells. Representative 
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data are presented in Fig. 2. C3H spleen cells depleted of nylon wool-adherent cells 
and of monocyte/macrophages by the carbonyl iron method showed 22.0 and 11.8% 
cytotoxicity against YAC-I and RLBI targets, respectively. In mixing experiments 
to measure allogeneic suppression, the mixture containing total thymocytes from 
B6 did not show any suppressive effect on NK activity of C3H spleen cells against 
YAC-I (19.0% cytotoxicity) and RL$I (11.0% cytotoxicity) target cells. Pooled 
thymocytes from fractions 15-18 showed significant suppression of NK activity of 
allogeneic C3H spleen cells against YAC-I (7.0% cytotoxicity) and RLaI (4.0% 
cytotoxicity) target cells, compared to lack of suppression obtained by total thy- 
mocytes or other fractions of thymocytes (P = ~0.01). Effector cells plus added 
thymocyte fractions 1-14 did not show any significantly decreased cytotoxicity 
against YAC-I and RL$I targets. Thymocyte fractions 19, 20, 21, 22, and 23-30 
also did not cause suppression of cytotoxicity of spleen cells against either target 
cell. The results thus demonstrate that suppression of NK activity is mediated by 
thymocyte fractions 15-l 8 and is active across the major histocompatibility barrier 
and as described above for syngeneic cells, no suppression is manifested by thy- 
mocyte fractions other than 15-l 8. 
Dose Response Effect of Suppressor Thymocytes on NK Activity of Syngeneic 
Spleen Cells 
The results of dose response analysis of the suppressive effect of B6 thymocytes 
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FIG. 2. Suppression of natural killer cell activity of young C3H (H-2k) spleen cells by allogeneic B6 
(H-2b) thymocyte fraction. See legend of Fig. 1 for E:T and S:E ratios used and for experimental details. 
Results are expressed as mean f SE of percentage direct cytotoxicity to target cells in triplicate cultures 
of a representative experiment; five separate experiments gave similar results. (a) Percentage cytotoxicity 
by C3H spleen cells alone; (b) percentage cytotoxicity by C3H spleen cells in presence of total thymocytes 
from 86; (c) percentage cytotoxicity by C3H spleen cells in presence of different fractions of B6 thy- 
mocytes. Results show significant suppression of NK activity of C3H spleen cells was mediated by the 
velocity-sedimented fractions 15-18 of allogeneic (B6) thymocytes (P ~0.01). 
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YAC-I target cells are shown in Fig. 3. The suppressive effect of pooled thymocyte 
fractions 15-18 on NK activity of spleen cells was noticeable at a S:E cell ratio 
of 1: 1. At an S:E ratio of 1: 1, the effector cells containing the active thymocyte 
pool (fractions 15-18) showed significant lowering of NK activity. NK activity of 
effector cells was decreased still further, when pooled thymocyte fractions 15-l 8 
were added at thymocyte to effector ratios of 2:l and 3: 1. Total thymocytes or 
pooled fractions of thymocytes, numbered 1-14 or 19-30, had little suppressive 
effect on the NK activity of effector spleen cells at any thymocyte to effector cell 
ratio. These results demonstrate a cell dose-dependent suppressive effect of pooled 
thymocyte fractions 15-18 on the NK activity of syngeneic effector cells against 
YAC-I target cells. 
Lack of Influence of Irradiation on Suppressive Effect of Thymocyte Fraction 
To examine the sensitivity of the suppressor thymocyte fraction to irradiation, 
pooled thymocyte fractions 15-18 were irradiated at 1000 and 2000 rad and their 
influence on the NK activity of effector cells against YAC-I target cells was studied. 
Representative data are shown in Fig. 4. Pooled thymocyte fractions 15-18, non- 
irradiated or irradiated at 1000 or 2000 rad, caused significant suppression of NK 
activity of autologous spleen cells against YAC-I target cells. No significant dif- 
ferences were observed in the suppression of NK activity of spleen cells against 
YAC-I target cells by irradiated suppressor cells versus nonirradiated suppressor 
cells at an SE ratio of 1: 1. The total thymocytes, irradiated at 1000 or 2000 rad 
or nonirradiated total thymocytes did not show any suppressive effect on NK ac- 
Om 3:l 
S:E RATIO 
FIG. 3. Dose response effect of suppressor thymocytes on NK activity of autologous spleen cells of B6 
mice. A constant E:T cell ratio of 50:1 was used. Prelabeled YAC-I cells were used as targets. S:E ratios 
of 1: 1, 2: 1, and 3: 1 were employed. Results are expressed as mean percentage f SE of direct cytotoxicity 
to target cells in triplicate cultures in a representative experiment; four separate experiments gave similar 
results. Results show a significant dose response suppressive effect of thymocyte fraction 15-l 8 on NK 
activity of autologous effector cells against YAC-I target cells compared to that of total thymocytes or 
other pooled fractions of thymocytes. 
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tivity of spleen cells against YAC-I target cells. These findings demonstrate that 
the suppressive action of thymocytes on NK activity was not sensitive to in vitro 
irradiation. 
The Thymocyte Fraction which Induced Suppression was Not Sensitive to NK- 
Mediated Cytolysis 
These experiments were designed to investigate whether suppression observed 
by thymocytes was due to cold target cell competitive inhibition of NK activity 
rather than actual suppression. Spleen cells, unfractionated thymocytes, and dif- 
ferent thymocyte fractions from 5- to 8-week-old B6 mice were labeled with “Cr 
as detailed under Materials and Methods. Splenocytes from the same animals were 
passed over nylon wool and the recovered cells were used as effector cells. Results 
of a representative experiment are presented in Table 1. At an E:T ratio of 5O:l 
or lOO:l, unseparated thymocytes or any of their fractions failed to show cytolysis 
by syngeneic spleen cells. No activity was observed against prelabeled spleen cells. 
The study thus revealed that thymocyte fractions 15-18 which showed significant 
suppression of NK activity of spleen cells did not contain antigenic determinants 
recognizable by the syngeneic NK cell and therefore suppression obtained in the 
present studies could not be attributed to cold target cell competitive inhibition, 
but rather to true suppression by thymocytes. 
a CONTROL 
cl 1000 RADS 
fJ 2000 RADS 
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THYMOCYTES FRACTION 15-18 
FIG. 4. Suppressive function of B6 thymocytes on NK activity of autologous spleen cells against YAC- 
1 target cells was not irradiation sensitive. Total thymocytes and fraction 15-l 8 were irradiated in vitro 
at 1000 and 2000 rad. E:T ratio of 50: 1 and S:E ratio of 1: I were used. Results are expressed as mean 
percentage f SE of direct cytotoxicity to target cells in triplicate culture of one respresentative exper- 
iment. Four separate experiments gave similar information. (@Percentage cytotoxicity of effector cells 
in presence of nonirradiated thymus fraction 15-18 or total thymocytes. (0)Percentage cytotoxicity of 
effector cells in presence of irradiated thymus fraction 15-18 or total thymocytes at 1000 rad. (QPer- 
centage cytotoxicity in presence of thymus fraction 15-18 or total thymocytes irradiated at 2000 rad. 
Results showed that thymocyte fraction 15-18-induced suppression of NK activity of spleen cells was 
not sensitive to 1000 or 2000 rad of y irradiation administered in vitro. 
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TABLE 1 
Cytotoxicity of Syngeneic Spleen Cells against Prelabeled Thymocytes and Their Various Fractions” 
Percentage cytotoxicity at 
E:T ratio 
Target cells 5O:l 1OO:l 
Total thymocytes 0.68 0.18 
Fractions 1-14 0.12 1.08 
Fractions 15-I 8 1.14 0.02 
Fraction 19 0.89 0.17 
Fraction 20 0.21 0.00 
Fraction 21 0.67 0.70 
Fraction 22 0.45 0.10 
Fractions 23-30 1.25 0.62 
Total spleen cells 0.89 0.28 
“Spleen cells did not show any cytotoxicity against prelabeled thymocytes or their fractions. Total 
thymocytes and their various fractions were labeled with “Cr as described under Materials and Methods 
and used as target cells. Syngeneic spleen cells depleted of nylon wool-adherent cells and monocyte/ 
macrophages, were used as effector cells. Effector to target cell ratios of 5O:l and 1OO:l were used. 
Results are expressed as mean percentage cytotoxicity to target cells in triplicate cultures of one rep- 
resentative experiment. Results show that unfractionated thymocytes or any of their subfractions are 
not sensitive to NK-mediated cytolysis by spleen cells. 
DISCUSSION 
Cells playing a regulatory role in the immune response have been widely studied 
and documented in murine systems. Most of the regulatory cells are thymocytes 
or are thymus-dependent cells. In the present studies, using cell mixing experiments 
to demonstrate inhibition, it was possible to show the presence of NK specific 
suppressor cells in a particular subpopulation of thymus cells. “Suppression” is 
operationally defined as the direct inhibition of cytolysis resulting from the addition 
of thymus cells or velocity sedimentation fractions to a mixture of functional NK 
effector cells and prelabeled target cells. No preincubation of the suppressor with 
the effector cells was used. 
Among different thymocyte fractions separated by a velocity sedimentation 
method, pooled cells of fractions 15-l 8 sedimenting at unit gravity at a rate between 
4 and 5 mm/hr showed consistent suppression of NK activity of young syngeneic 
as well as allogeneic spleen cells against YAC-I and RL$I target cells, compared 
to earlier or later fractions or unseparated thymocytes. The suppression observed 
by pooled fractions 15-18 of thymocytes does not appear to be due to crowding, 
spacing, or dilution of effector cells, since effector cells mixed with equal numbers 
of total thymocytes or differentially sedimenting subpopulations showed no suppres- 
sion of the NK activity of effector cells. 
The suppressive functions were resistant to irradiation administered in vitro and 
in this characteristic are like the suppressor cells of spleen described by Cudkowicz 
and Hochman ( 16). Studies of other characteristic features of the pooled thymocyte 
fractions 15-l 8 in our laboratory have shown these fractions to contain large lym- 
phocytes that are nonspecific esterase negative and contain the highest content of 
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terminal deoxynucleotidyl transferase (TdT) activity, a marker enzyme for pre- 
cursor T cells or immature thymocytes4.‘. 
Pazmino et al. (17) and Small et al. (18) have recently reported that bone 
marrow from nu/nu Swiss mice and neonatally thymectomized C57BL/6 mice has 
a lo-fold reduction in TdT activity. Interestingly, nu/nu mice or neonatally thy- 
mectomized mice express a high percentage of NK cells (9) perhaps because NK 
specific suppressor cells presumably derived from the thymus are lacking in their 
marrow. This finding is consistent with our observation that NK specific suppressor 
cells appear to be TdT positive thymus-derived lymphocytes. 
Small and Trainin ( 19) and Gabizon et al. (20) have demonstrated that tumor- 
inhibiting T cells in the spleens of tumor-bearing mice are gradually overwhelmed 
by a dominating population of tumor enhancing T cells as the tumor progresses. 
This change could be correlated with enlargement of the spleen and involution of 
thymus (20-22). Small et al. ( 18) and Umiel et al. (23) recently postulated that 
thymocytes of tumor-bearing animals might be released prematurely into the spleen 
and that they then might be involved in eclipse of antitumor activity and conse- 
quently enhancement of tumor growth. Such cells have been identified in spleen 
as TdT positive cells, a marker for thymus-derived cells. In the present report, 
pooled TdT-enriched thymocyte fractions 15-l 8, separated by velocity sedimen- 
tation and capable of manifesting significant suppression of the NK activity of both 
syngeneic and allogeneic spleen cells, may be identical with the tumor enhancing 
T-cell subpopulation of tumor-bearing mice reported by Small et al. ( 18) and Umiel 
et al. (23). Further characterization of these NK specific suppressor cells with 
respect to their ontogeny, tissue distribution, migratory and regulatory functions, 
both in normal and pathological conditions remains to be done. 
The NK suppressive fraction of thymocytes was not sensitive to lysis by autol- 
ogous spleen cells, suggesting that the suppression obtained in the present studies 
was not due to cold target cell competitive inhibition of NK activity by thymus 
cells. In previous studies Nunn, et al. (7) reported that spleen cells from Balb/c 
nude mice showed NK activity against thymus cells from different strains of mice. 
However, allogeneic or syngeneic spleen cells failed to show any cytotoxic reactivity 
against prelabeled thymocytes. Our study in which we observed no reactivity with 
syngeneic spleen cells against prelabeled thymus cells is consistent with the findings 
of Nunn et al. In similar experiments Hansson et al. (8) recently observed NK 
sensitivity of thymocytes from various strains of mice with high or low NK activity. 
They have reported that NK sensitivity of thymocytes varied markedly with the 
age of the thymocyte donor, reaching a peak at less than l-2 weeks of age and no 
such sensitivity of thymocytes to NK-mediated lysis was seen in thymocyte pop- 
ulations of mice more than 3 weeks old. They also reported an inverse correlation 
between age dependence of splenic NK activity and the sensitivity of thymocytes 
to NK-mediated lysis. Therefore our findings which show a lack of NK sensitivity 
of a thymocyte population to spleen cells in mice aged 5-8 weeks is consistent with 
‘R. N. Pahwa, M. J. Modak, T. McMorrow, S. Pahwa, G. Fernandes, and R. A. Good, Terminal 
deoxynucleotidyl transferase enzyme in thymus and bone marrow. I. Age associated decline of TdT in 
humans and mice. Cell. Immunol. 58, 39, 1981. 
’ S. Ikehara, R. N. Pahwa, D. G. Luszer, R. A. Good, and M. J. Modak, Adenosine 5’-triphosphate 
(ATP)-mediated stimulation and suppression of DNA synthesis. I. Characterization of ATP responding 
cells in mouse lymphoid organs. Submitted for publication. 
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our previous observations of peak NK reactivity in spleen at that period (24). Thus 
it is an exciting possibility that a feedback type of homeostatic control mechanism 
exists between thymus and spleen cells as the mice age. 
The present study suggests that suppression of NK cytolysis in vitro by certain 
fractions of thymocytes may reflect a capacity for immunoregulatory activity of 
similar subpopulations on NK activity in vivo. Further characterization of these 
suppressor thymocytes could have the following significance: (i) If NK cells are 
involved in immune surveillance of malignancies (25) then enhancing their effects 
in premalignant and malignant states by diminishing NK specific suppressor ac- 
tivities could have significant benefit in the prevention or treatment of cancer. (ii) 
Evidence indicates that the identity of the effector cells involved in resistance to 
marrow transplantation is similar to NK cells (26), thus a reciprocal clinical sit- 
uation, where effector cells could be inhibited and suppressor cell activity enhanced 
might be capable of prolonging marrow allografts in the treatment of leukemias, 
lymphomas, and immunodeficiencies. 
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